Literature DB >> 3938624

Neuropathological study and chemico-pathological correlation in sibling cases of Sanfilippo syndrome type B.

K Tamagawa, Y Morimatsu, K Fujisawa, A Hara, T Taketomi.   

Abstract

Pathological and biochemical studies of two sibling cases (18-year-old girl and 16-year-old boy) with Sanfilippo syndrome type B are presented. Pathological study revealed distended neurons and neuronal processes with inclusions throughout the CNS and the visceral organs, and neuronal loss and corresponding gliosis. The authors paid particular attention to atrophic changes in the thalamus and to "dissociation gliomyélinique" in the cerebral white matter. Histochemistry and electron microscopy revealed regional differences in stored materials. Biochemical studies revealed an accumulation of glycosaminoglycans in the CNS and abnormalities in the lipid metabolism in the brain and visceral organs. A protein assay of the cerebrum showed increased glial fibrillary acidic protein and low levels of myelin basic protein in the white matter.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3938624     DOI: 10.1016/s0387-7604(85)80008-5

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  10 in total

1.  Storage vesicles in neurons are related to Golgi complex alterations in mucopolysaccharidosis IIIB.

Authors:  Sandrine Vitry; Julie Bruyère; Michaël Hocquemiller; Stéphanie Bigou; Jérôme Ausseil; Marie-Anne Colle; Marie-Christine Prévost; Jean Michel Heard
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

2.  Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery.

Authors:  Haiyan Fu; Aaron S Meadows; Tierra Ware; Robert P Mohney; Douglas M McCarty
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

3.  Klüver-Bucy syndrome associated with a recessive variant in HGSNAT in two siblings with Mucopolysaccharidosis type IIIC (Sanfilippo C).

Authors:  Hao Hu; Christoph Hübner; Zoltan Lukacs; Luciana Musante; Esther Gill; Thomas F Wienker; Hans-Hilger Ropers; Ellen Knierim; Markus Schuelke
Journal:  Eur J Hum Genet       Date:  2016-11-09       Impact factor: 4.246

4.  NAGLU mutations underlying Sanfilippo syndrome type B.

Authors:  A Schmidtchen; D Greenberg; H G Zhao; H H Li; Y Huang; P Tieu; H Z Zhao; S Cheng; Z Zhao; C B Whitley; P Di Natale; E F Neufeld
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

5.  Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy.

Authors:  Virginia Haurigot; Sara Marcó; Albert Ribera; Miguel Garcia; Albert Ruzo; Pilar Villacampa; Eduard Ayuso; Sònia Añor; Anna Andaluz; Mercedes Pineda; Gemma García-Fructuoso; Maria Molas; Luca Maggioni; Sergio Muñoz; Sandra Motas; Jesús Ruberte; Federico Mingozzi; Martí Pumarola; Fatima Bosch
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

6.  Serum global metabolomics profiling reveals profound metabolic impairments in patients with MPS IIIA and MPS IIIB.

Authors:  Haiyan Fu; Aaron S Meadows; Ricardo J Pineda; Robert P Mohney; Steve Stirdivant; Douglas M McCarty
Journal:  Metab Brain Dis       Date:  2017-04-05       Impact factor: 3.584

7.  Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC.

Authors:  Sara Marcó; Anna Pujol; Carles Roca; Sandra Motas; Albert Ribera; Miguel Garcia; Maria Molas; Pilar Villacampa; Cristian S Melia; Víctor Sánchez; Xavier Sánchez; Joan Bertolin; Jesús Ruberte; Virginia Haurigot; Fatima Bosch
Journal:  Dis Model Mech       Date:  2016-08-04       Impact factor: 5.758

8.  Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency.

Authors:  Parisa Lotfi; Dennis Y Tse; Alberto Di Ronza; Michelle L Seymour; Giuseppe Martano; Jonathan D Cooper; Fred A Pereira; Maria Passafaro; Samuel M Wu; Marco Sardiello
Journal:  Autophagy       Date:  2018-07-23       Impact factor: 16.016

9.  Blood-brain barrier impairment in MPS III patients.

Authors:  Svitlana Garbuzova-Davis; Santhia Mirtyl; Sebastian A Sallot; Diana G Hernandez-Ontiveros; Edward Haller; Paul R Sanberg
Journal:  BMC Neurol       Date:  2013-11-13       Impact factor: 2.474

10.  Amyloidosis, synucleinopathy, and prion encephalopathy in a neuropathic lysosomal storage disease: the CNS-biomarker potential of peripheral blood.

Authors:  Bartholomew J Naughton; F Jason Duncan; Darren Murrey; Tierra Ware; Aaron Meadows; Douglas M McCarty; Haiyan Fu
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.